# Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival

> **NCT01640171** · NA · COMPLETED · sponsor: **Retina Vitreous Associates of Florida** · enrollment: 57 (actual)

## Conditions studied

- Age-related Macular Degeneration
- Central Retinal Vein Occlusion
- Diabetic Macular Edema

## Interventions

- **PROCEDURE:** Xylocaine 2% Injectable Anesthetic
- **DRUG:** Proparacaine Hydrochloride 0.5% Drop
- **DRUG:** Tetravisc 0.5% Gel
- **DRUG:** Acuvail
- **DRUG:** Intra-vitreal Anti-VEGF Drug

## Key facts

- **NCT ID:** NCT01640171
- **Lead sponsor:** Retina Vitreous Associates of Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-09
- **Final completion:** 2013-10
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01640171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01640171, "Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01640171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*